Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kamau Therapeutics

Clinical trials sponsored by Kamau Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy breakthrough? new treatment aims to fix sickle cell at the source Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Gene therapy breakthrough? new treatment aims to fix sickle cell at the source

Disease control Recruiting now

This early-stage trial is testing a new gene therapy called nula-cel for people with severe sickle cell disease. The therapy modifies a patient's own blood stem cells to produce normal hemoglobin instead of sickle hemoglobin. About 15 participants aged 12 to 40 will receive the t…

Phase 1/2 • Sponsor: Kamau Therapeutics • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC